Acquisition - February 5, 2015
Symphogen, Merck End Pact
Danish biotech company Symphogen once again has its lead asset in its portfolio, experimental cancer drug Sym004, three years after it partnered with Merck on a $625 million deal for its development. The two companies said recently that they have ended their collaboration, with Symphogen saying it hopes to now turn itself into a standalone […]
Uncategorized - February 5, 2015
Athena Prize Goes to Cancer Vaccine
Sweden’s Athena Prize, healthcare’s largest prize for clinical research, was awarded this year to physician and Associate Professor Alex Karlsson-Parra, of Uppsala University Hospital and founder of the company Immunicum. The company specializes in developing therapeutic cancer vaccines. The prize, which consists of a research grant of $150 000, was awarded in December at the Swedish […]
Intellectual Property - February 5, 2015
FDA, Veloxis Dispute Continues
The U.S. Food and Drug Administration (FDA) has informed Veloxis Pharmaceuticals A/S that the FDA still maintains that the exclusivity for Astagraf XL should require delays in the formal approval of Envarsus® XR. The FDA has stated that it would be prepared to approve Envarsus XR for use only in patients transitioned from an immediate […]
Acquisition - February 5, 2015
Share Issue for Ultimovacs
Norway’s Ultimovacs AS has carried out a successful NOK 45 million share issue with DNB Markets and Arctic Securities as financial advisors. The issue was fully subscribed by new shareholders. The two biggest new shareholders are Canica AS and Sundt AS. Ultimovacs is a biotechnology company that develops a therapeutic universal cancer vaccine. The treatment […]
Acquisition - February 5, 2015
Cortendo Gains Investors
Cortendo AB, a Swedish global biopharmaceutical company focused on orphan endocrine disorders, has entered agreements with U.S. institutional specialist healthcare investors RA Capital Management, New Enterprise Associates (NEA) and Broadfin Capital. HealthCap, a leading European venture capital healthcare investor, also agreed to increase its existing investment in the company, bringing this private placement to a […]
Uncategorized - February 5, 2015
Nordic Registries and Biobanks Report Available
A joint Nordic Registers and Biobanks report was published in December, providing health and welfare researchers with a wealth of information. The registers and biobanks can provide policy-makers with research-based knowledge to improve the operation of Nordic countries. The report is based on the work of the NORIA-net on Registers and Biobanks (NRB), a Nordic working group […]
